56461-33-7

Usage

InChI:InChI=1/C17H14O3/c18-16(11-5-2-1-3-6-11)14-8-4-7-12-13(14)9-10-15(12)17(19)20/h1-8,15H,9-10H2,(H,19,20)

Upstream product

• 56461-64-4 4-benzylindan-1-carboxylic acid 
• 56461-72-4 ethyl 4-benzoylindan-1-carboxylate 
• 56461-35-9 4-benzoylindan-1-carboxamide 
• 56486-31-8 4-benzoylindan-1-carbonitrile 

Downstream Products

• 56461-85-9 N-methyl-4-benzoylindan-1-carboxamide 
• 56461-35-9 4-benzoylindan-1-carboxamide 
• 56461-72-4 ethyl 4-benzoylindan-1-carboxylate 
• 56461-84-8 N-hydroxy-4-benzoylindan-1-carboxamide 
• 56461-86-0 4-(4-benzoyl-indan-1-carbonyl)-morpholine 
• 59101-76-7 R-d-4-Benzoyl-1-indancarbonsaeure 
• 59101-77-8 S-l-4-Benzoyl-1-indancarbonsaeure 

Relevant academic research and scientific papers

Derivatives of antiphlogistically effective carboxylic acids, their preparation and medicinal use

Compounds of Formula I STR1 wherein R1 is the residue of an antiphlogistically effective carboxylic acid of the formula R1 COOH, n is an integer 1, 2, or 3, and X is oxygen, sulfur, or optionally alkylated nitrogen have valuable antiinflammatory activity.

Benzalicyclic carboxylic acid derivative

Compounds of the formula: SPC1 Wherein R1 is an aryl group which may be substituted, R2 is hydrogen or a lower alkyl group having 1 to 4 carbon atoms and n is 1 or 2, or derivatives at the carboxyl function thereof, are useful as medicines such as antipyretics, analgesics and anti-inflammatory agents.